Clinical trial · Observational
Development of the Polycystic Ovary Syndrome Symptoms Inventory
Polycystic Ovary Syndrome Symptoms Inventory: Development, Validity and Reliability in Turkey
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Polycystic Ovary Syndrome Symptom Severity and Distress Inventory: Development, Validity and Reliability in Turkey The goal of this observational study is to develop and validate a self-report inventory that assesses Polycystic Ovary Syndrome (PCOS) symptoms and the level of distress experienced by women diagnosed with PCOS. The main question it aims to answer is: Is the newly developed inventory a valid and reliable instrument for assessing PCOS symptoms and related distress in women? Participants will answer online survey questions including a demographic information form and three scales evaluating psychological health and PCOS related symptoms, including the newly developed symptom and distress inventory.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
| Psychological Distress | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Women diagnosed with PCOS
- description
- Women aged 18-49 who report having been diagnosed with PCOS will be included in the study.
Primary outcomes (1)
- measure
- Polycystic Ovary Syndrome Symptom Severity and Distress Inventory
- timeFrame
- At the time of survey completion (Baseline)
- description
- The newly developed inventory consists of 34 items in total, with 17 items dedicated to evaluating PCOS symptom severity and 17 items for measuring distress levels. Each item is scored on a scale from 0 to 10. Total scores are calculated separately for symptom severity and distress levels, with each score ranging from 0 to 100. Higher scores on these measurements indicate an increase in both symptom severity and the level of distress experienced by the participant.
Secondary outcomes (3)
- measure
- Participant Information Form
- timeFrame
- At the time of survey completion (Baseline)
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 49 Years
Show eligibility criteria text
Inclusion Criteria: * Being a woman aged 18-49 (of reproductive age) who states she has been diagnosed with PCOS * Being able to read and understand Turkish * Volunteering to participate in the study Exclusion Criteria: * Having a disease that could cause symptoms similar to PCOS (such as Cushing's syndrome, thyroid dysfunction, hyperprolactinemia, androgen-secreting tumors)
References
Publications (0)
Data not yet available